Finance

Beta
Lists
GOVX:NASDAQ
Geovax Labs Inc
$1.29
-2.27%
(-0.030) 1D
$1.25
-3.10% (-0.040)
After hours
Closed: Jun 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GOVX...
Open
$1.27
High
$1.34
Low
$1.26
Mkt. cap
4.48M
Avg. vol.
10.19M
Volume
204.66K
52-wk high
$24.50
52-wk low
$0.96
EPS
-$21.69
Beta
3.62
Shares outstanding
5.21M
No. of employees
19
Open
$1.27
High
$1.34
Low
$1.26
Mkt. cap
4.48M
Avg. vol.
10.19M
Volume
204.66K
52-wk high
$24.50
52-wk low
$0.96
EPS
-$21.69
Beta
3.62
Shares outstanding
5.21M
No. of employees
19
News stories
From sources across the web
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com
Analyst Ratings
Based on 2 analysts giving stock ratings to GOVX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GOVX in the last 3 months.
Highest
Current $1.29
$10.00 (+675.19%)
Average
$10.00 (+675.19%)
Lowest
$10.00 (+675.19%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
$10.00
+675.2%
05/27/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$10.00
+675.2%
05/26/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
852.28K
-
-
-
Cost of goods sold
4.73M
5.04M
2.99M
3.90M
Cost of revenue
4.73M
5.04M
2.99M
3.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.54M
1.33M
1.45M
1.37M
Operating expense
1.54M
1.33M
1.45M
1.37M
Total operating expenses
6.27M
6.37M
4.44M
5.27M
Operating income
-5.42M
-6.37M
-4.44M
-5.27M
Other non operating income
-
-
-
-
EBT including unusual items
-5.37M
-6.32M
-4.42M
-5.26M
EBT excluding unusual items
-5.37M
-6.32M
-4.42M
-5.26M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.37M
-6.32M
-4.42M
-5.26M
Net profit margin
-630.05%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
49.12K
54.30K
23.33K
10.96K
Interest expense
-
-
-
-
Net interest expenses
49.12K
54.30K
23.33K
10.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.40M
-6.36M
-4.42M
-5.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer